We're a collaborative non-profit Institute focused on understanding the power of the immune system. Our goal is to advance human health through immunology. We've created an efficient assay to detect SARS-CoV-2 particles in saliva samples without the need for RNA extraction, which was developed and optimized within three weeks, from idea to launch and XPRIZE entry in August 2020. By December 2020, we completed 11 full pilots, ensuring clinical rigor.